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ABSTRACT
Background and Aims Digital interventions are effective for reducing alcohol consumption but evidence is limited re-
garding smartphone apps. Drink Less is a theory‐ and evidence‐informed app to help people reduce their alcohol consump-
tion that has been refined in terms of its content and design for usability across the sociodemographic spectrum.We aim to
evaluate the effectiveness and cost‐effectiveness of recommending Drink Less at reducing alcohol consumption compared
with usual digital care. Design Two‐arm individually randomised controlled trial. Setting Online trial in the United
Kingdom (UK). Participants Hazardous or harmful drinkers (Alcohol Use Disorders Identification Test [AUDIT] score
≥8) aged 18+whowant to drink less alcohol (n= 5562). Participants will be recruited from July 2020 to May 2022 using
multiple strategies with a focus on remote digital methods. Intervention and comparator Participants will be
randomised to receive either an email recommending that they use Drink Less (intervention) or view the National Health
Service (NHS) webpage on alcohol advice (comparator).Measurements The primary outcome is change in self‐reported
weekly alcohol consumption, assessed using the extended AUDIT‐Consumption, between baseline and 6‐month follow‐up.
Secondary outcomes include change in self‐reported weekly alcohol consumption assessed at 1‐ and 3‐month follow‐ups,
and the proportion of hazardous drinkers; alcohol‐related problems and injury; health‐related quality of life; and use of
health services assessed at 6‐month follow‐up. Effectiveness will be examined with adjusted regression models, adjusting
for baseline alcohol consumption and using an intention‐to‐treat approach. A mixed‐methods process evaluation will as-
sess engagement, acceptability andmechanism of action. Economic evaluations will be conducted using both a short‐ and
longer‐term time horizon. Comments This study will establish the effectiveness and cost‐effectiveness of the Drink Less
app at reducing alcohol consumption among hazardous and harmful adult drinkers and will be the first randomised con-
trolled trial of an alcohol reduction app for the general population in the United Kingdom. This study will inform the de-
cision on whether it is worth investing resources in large‐scale implementation.
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INTRODUCTION
Hazardous and harmful alcohol consumption is a major
public health concern and contributes to health inequal-
ities with the most deprived groups suffering the most
harm from alcohol [1]. Fewer than 7% of hazardous and
harmful drinkers receive face‐to‐face interventions in pri-
mary care to support alcohol reduction [2] with key bar-
riers to the delivery of these interventions by practitioners
being lack of time and low confidence about discussing al-
cohol with patients [3,4]. Digital interventions, such as
websites and smartphone apps, may be effective for reduc-
ing alcohol consumption [5] and may overcome barriers to
delivery of face‐to‐face interventions because they poten-
tially have a broad reach and relatively low implementa-
tion costs (once developed) and therefore can be delivered
at scale [6]. As digital technologies become more inte-
grated into everyday life and widely used, digital interven-
tions can have a large positive impact on public health and
well‐being at a population level. Smartphone apps are a
promising mode of intervention delivery because
smartphones have become increasingly affordable to end
users and prevalent among the United Kingdom (UK) pop-
ulation [7]. However, most digital alcohol interventions
that have been evaluated are web‐based and there is little
evidence on the effectiveness of apps. The few trials of apps
have been based in other countries and usually with youn-
ger adults [8–11]. Therefore, there is an urgent need for a
robust evaluation of an evidence‐ and theory‐informed al-
cohol reduction app, which, if effective, could bewidely rec-
ommended to drinkers in the UK. The Drink Less app was
designed to help people reduce their alcohol consumption
and has been developed and refined using a systematic
and iterative process [12,13]. The app is ready for a defin-
itive evaluation to establish whether recommending it to
people is more effective than usual digital care for the re-
duction of alcohol consumption.
Digital interventions—primarily web‐based—may re-
duce alcohol consumption, with an average reduction of
23g of alcohol (2.9 UKunits) per week compared with par-
ticipants in the control group [5]. In this Cochrane review
of 42 randomised controlled trials (RCTs), only one of the
digital interventions used a smartphone app, and this
RCT was conducted in Sweden among university students,
which found that the app may have led to a negative effect
among men [8]. Updates of this review found a further
three studies that used smartphone apps: one in Sweden
among university students (that found the app had poten-
tial for reducing excessive alcohol use) [9], one for the gen-
eral population in Canada (that found that access to the
app had no impact on drinking) [10] and another for
young adults in Australia (that found a decrease in the typ-
ical number of drinks on a drinking occasion in both condi-
tions) [11]. Therefore, despite the availability of hundreds
of alcohol‐related apps, none have been evaluated in a
RCT among the general population of adults in the
United Kingdom. The majority have also been developed
without reference to scientific evidence or theory [14].
The lack of evidence highlights the necessity of a robust
and pragmatic evaluation of an evidence‐ and theory‐in-
formed alcohol reduction app, which, if effective, could be
widely recommended.
Drink Less is an evidence‐ and theory‐informed app
that aims to help hazardous and harmful drinkers re-
duce their alcohol consumption. Drink Less is one of
the most popular alcohol reduction apps on the UK Ap-
ple app store and is highly rated by users, and is capable
of reaching a large proportion of the UK population at a
low incremental cost. The development and evaluation
of Drink Less was guided by the Medical Research Coun-
cil’s guidance on complex interventions [15] and the
Multiphase Optimisation Strategy [16]. The development
of the Drink Less app was informed by the COM‐B model
of behaviour [17] and multiple sources of evidence
[14,18,19] meaning it has a robust theoretical basis
and evidence base. The COM‐B model posits that behav-
iour results from interactions between ‘capability’, ‘op-
portunity’, and ‘motivation’, and was used to provide
an overarching theoretical structure [17]. The empirical
evidence and theoretical framework provided the basis
for the prioritisation of intervention components to in-
clude in the app. Drink Less consists of seven key mod-
ules: (i) Goal Setting; (ii) Self‐Monitoring and Feedback;
(iii) Normative Feedback; (iv) Cognitive Bias Retraining;
(v) Action Planning; (vi) Behavioural Substitution; and
(vii) Information About Antecedents. Details of these
modules are reported in full elsewhere [12]. A factorial
screening trial was conducted to identify the most effec-
tive modules (distinct behaviour change interventions)
within the app, which established that four of the five
original modules appeared to have an effect on reducing
alcohol consumption after 4 weeks if combined with one
of the other modules [13]. Data also suggested that
users of Drink Less found it to be engaging [13], which
is important to reduce participant attrition. The strategy
for refining the effectiveness and usability of the app was
based on: (i) findings from the previous factorial trial; (ii)
a content analysis of user feedback (that indicated that
users found it helpful in reducing their drinking); and
(iii) an updated evidence review and meta‐analysis of be-
haviour change techniques in digital alcohol interven-
tions. The refinement process is reported in full
elsewhere (under review). Both the initial development
and refinement of Drink Less have involved input from
users across the social spectrum on the functionality, de-
sign and language used in the app [20]. The same ap-
proach was used for a smoking cessation digital
intervention that was found to be effective for increasing
Evaluating the Drink Less app: RCT protocol 413
© 2020 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction Addiction, 116, 412–425
smoking cessation rates across different socioeconomic
groups [21].
The next step in the Multiphase Optimisation Strategy
is to conduct a RCT to evaluate the long‐term effectiveness
and cost‐effectiveness of the digital recommendation of the
refined Drink Less app, compared with alcohol advice from
the National Health Service (NHS) alcohol advice webpage
(usual digital care, available to anyone seeking alcohol sup-
port), in reducing alcohol consumption among hazardous
and harmful drinkers. This research will be the first RCT
of an alcohol reduction app for the general population in
the United Kingdom and will evaluate whether it is worth
investing resources into promoting and disseminating the
app on a larger scale. The aim of this trial is to evaluate
the effectiveness and cost‐effectiveness of recommending
Drink Less at reducing alcohol consumption compared
with usual digital care.
Research questions
1 Among hazardous and harmful drinkers, does the digi-
tal recommendation to use Drink Less compared with
the NHS alcohol advice webpage reduce weekly alcohol
consumption (in UK standard units) between baseline
and 6‐month follow‐up?
2 Among hazardous and harmful drinkers, does the digi-
tal recommendation to use Drink Less compared with
the NHS alcohol advice webpage:
a Reduce weekly alcohol consumption (in UK standard
units) between baseline and 1‐ and 3‐month follow‐up?
b Reduce heavy episodic alcohol consumption at 6‐month
follow‐up?
c Reduce the proportion of hazardous drinkers at 6‐
month follow‐up?
d Reduce alcohol‐related problems and injury, and use of
healthcare services at 6‐month follow‐up?
e Improve health‐related quality of life at 6‐month follow‐
up?
3 What is the extent of user engagement with Drink Less
and does user engagement moderate these outcomes?
4 Through what psychological measures does engage-
ment with Drink Less change drinking behaviour?
5 What are participants’ views on the acceptability of the
intervention?
6 What is the cost‐utility and potential impact on health
inequalities of Drink Less compared with the NHS alco-
hol advice webpage in terms of reduction in alcohol con-
sumption and health‐related quality of life using a short
time horizon?
7 What is the longer‐term cost‐effectiveness and potential
impact on health inequalities of Drink Less compared
with the NHS alcohol advice webpage, if rolled out on
a national level through active promotion to the public,
over a 20‐year period?
METHODS
Design
A two‐arm, parallel group, RCT with a 1:1 allocation com-
paring the recommendation to use the intervention (Drink
Less) with usual digital care (the NHS alcohol advice
webpage), with an embedded mixed‐methods process
evaluation.
Setting
The study will take place online with participants who live
in the UK.
Participants
Participants will be included if they: are aged 18 years or
over, live in the UK, are hazardous and harmful drinkers
(Alcohol Use Disorders Identification Test (AUDIT) score
≥8), have access to an iOS device (i.e. iPhone, iPod touch
or iPad, because Drink Less is currently only available on
these devices) and want to drink less alcohol. Participants
will be excluded if they are unwilling to complete
follow‐up assessments or are unable to read English (for
pragmatic reasons), which will be assessed with a Yes/No
question in the screening questionnaire.
Recruitment
Recruitment is due to run from July 2020 to March 2022
via a multi‐pronged strategy including: an advertisement
on the NHS website; a mail‐out to a database of UK‐based
users of the Smoke Free app; and press releases and local
advertising through health care providers and/or national
and local government colleagues. The advertisements will
be co‐developed with public representatives.
Sample size
A sample size of 5562 participants (2781 in the compara-
tor group and 2781 in the intervention group) is required
to detect a mean difference reduction of 2 UKunits (16 g of
alcohol) in weekly alcohol consumption (the primary anal-
ysis) at 90% power with an α of 0.05 and a two‐tailed test.
This was calculated using G*Power software [22]. The esti-
mated effect size is in line with the Cochrane reviewon dig-
ital alcohol interventions [5] and is roughly equivalent to
that found in face‐to‐face brief interventions [23].
An initial sub‐sample of 26 participants (13 from each
group [24]), who consented to a short interview about
their experience of the trial, will be selected after the 6‐
month follow‐up, as part of the mixed‐methods process
evaluation. Participants will be purposively sampled to
achieve good diversity in terms of sociodemographic char-
acteristics and with high and low engagement. Data will
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be analysed and data collection will continue only if the-
matic ‘meaning’ saturation is not reached (see Analysis).
Collection will continue in an iterative process (adding 10
participants at a time) until saturation is reached.
Intervention
Drink Less is a stand‐alone app‐based intervention that is
freely available via the Apple app store in the UK [25].
Drink Less was developed for hazardous and harmful
drinkers to help them reduce their alcohol consumption.
Drink Less consists of evidence‐basedmodules to help users
change their drinking behaviour: Goal Setting, setting
weekly ‘drinking reduction’ goals; Self‐Monitoring and
Feedback, monitoring alcohol consumptions and seeing
progress on goals; Action Planning, creating plans for deal-
ing with difficult drinking situations; Normative Feedback,
providing personalised feedback on how an individual’s
drinking behaviour compares to the norm; Cognitive Bias
Re‐Training, a game for retraining users’ automatic biases
for alcoholic drinks; Behavioural Substitution, planning to
substitute drinking with a neutral behaviour; and Informa-
tion about Antecedents, providing users with information
about situations and events, emotions and cognitions that
predict their drinking. These evidence‐based modules map
to behaviour change techniques (Fig. 1). The development
and content of the original Drink Less version is reported in
full elsewhere [12] and the refined version is reported on-
line (https://osf.io/mc8yz/). The app contains standard fea-
tures such as the UK Chief Medical Officers’ low‐risk
drinking guidelines (14 units a week) [26].
On downloading the app, users are asked to complete
the AUDIT, provide sociodemographic details and then
receive the Normative Feedback module. Users are then
guided through setting a goal and shown how to use
the key features of the app. Users can access all of the
modules from the dashboard and the menu bar. The
dashboard (the landing page of the app) has suggestions
for the user to complete each day, as well as features of
and links to the modules. Users can choose to have daily
reminders to complete their drinks and mood diary for
the previous day. The app provides a ‘toolbox’ of features
for users to choose from and access as and when they
want. The app is not tailored to the user except for
personalised feedback in two modules: Normative Feed-
back and Self‐Monitoring and Feedback. Any modifica-
tions to the app during the trial (e.g. bug fixes) will be
documented and reported.
Drink Less is expected to reduce the alcohol consump-
tion of its users based on (i) its robust theoretical basis
Figure 1 Logic model for the process of change of the Drink Less app (developed by the internal research team). [Colour figure can be viewed at
wileyonlinelibrary.com]
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(the COM‐Bmodel of behaviour) [17]; (ii) its evidence base;
and (iii) user feedback that indicates users believe that it
helps them to reduce their drinking and has a positive effect
on their health and well‐being. It is also expected to reduce
urges to drink, increase motivation to drink less and in-
crease self‐regulatory capacity to drink less (see Fig. 1 for
the logic model). Drink Less is also highly rated by users
(average 4.2‐star rating in the Apple (UK) App Store with
over 60 000 unique users as of 1 November 2019).
Comparator
The comparator group will receive the recommendation to
view the NHS alcohol advice webpage on ‘Tips on
cutting down’ that also has links to other webpages
aimed at hazardous and harmful drinkers [27]. This can
be considered reflective of ‘usual digital care’ in this context
because it is the digital support currently available to
treatment‐seeking individuals from the NHS. Therefore,
this comparator best serves the primary purpose of the trial
[28], which is to investigate whether it is worth promoting
Drink Less over the ‘usual digital care’ and is of direct
policy relevance. Furthermore, it is important to have a
comparator that is relevant to the same target population
as the intervention, and both Drink Less and the NHS
webpage are aimed at adults in the general population.
Any changes to the comparator during the trial will be
documented.
This is a pragmatic trial where participants have access
to awide range of digital support and therefore it is not pos-
sible to simply compare use of the Drink Less app with use
of the NHS webpage to assess which is more effective. In-
stead, the pragmatic nature of the trial means the evalua-
tion is in terms of whether the recommendation of the
Drink Less app enhances usual digital care over and above
what is currently used by the participant.
Procedure
Figure 2 illustrates the study design and flow of partici-
pants and Table 1 summarises the schedule of enrolment
and follow‐up assessment for trial participants.
Eligibility assessment
Participants will self‐enrol into the study and potential par-
ticipants will be asked to respond to a web‐based screening
questionnaire to assess the inclusion and exclusion criteria,
including the full AUDIT with the timeframe of the past
6 months (see Measures).
Figure 2 Flowchart of procedure
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Consenting
If people meet the eligibility criteria they will be shown
the information sheet (https://www.ucl.ac.uk/epidemiol-
ogy‐health‐care/sites/epidemiology‐health‐care/files/parti
cipant_information_sheet.pdf) and informed that they
will be re‐contacted on three occasions (at 1, 3 and
6 months). Participants will then be asked to provide con-
sent online to participate in the study.
Baseline assessment
Participants will complete a web‐based assessment of
sociodemographic measures (see Measures) and their con-
tact details (email address, telephone number and postal
address) for follow‐up assessments.
Randomisation
Participants who complete the baseline assessment will be
randomised individually to intervention and comparator
groups using block randomisation (block size of 50) and a
random allocation sequence generated by an online auto-
mated algorithm (at a ratio of 1:1). Participants will be
blinded to study arm. There will be no involvement of the
researchers in the randomisation process, and there will
be complete allocation concealment.
Intervention and comparator delivery
Participants will be emailed within 24 hours of the baseline
assessment and randomisation with the recommendation
to either use Drink Less (the intervention) or the NHS alco-
hol advice webpage (comparator). Participants allocated to
the intervention condition will be provided with instruc-
tions on how to download the Drink Less app. Participants
in both conditions will be provided with the contact details
of the project teamwhowill provide ongoing technical sup-
port, if required, during office hours. These emails will be
co‐developed with public representatives.
Follow‐up assessments
Follow‐up assessments will be conducted 1, 3 and
6 months after baseline. The 6‐month follow‐up assess-
ment will assess the primary and secondary outcomemea-
sures and psychological measures; the follow‐up
assessments at 1 and 3 months will assess the
self‐reported weekly alcohol consumption only. Partici-
pants will have up to 30 days to complete each survey to
maximise data retention. Participants will be sent up to
three automated emails with a link to a web‐based survey
for the follow‐up assessments on days 0, 5 and 9. Partici-
pants who do not complete theweb‐based follow‐up assess-
ment will be sequentially offered opportunities to do so via
phone (called once per day on days 10–17), mailed survey
(on day 18) and by postcard (on day 30). Participants will
be compensated with gift vouchers of up to £36 for com-
pleting the three surveys: £6 for the survey at 1 and
3 months; £12 at 6 months with an additional £12 if the
6‐month survey is completed within 24 hours.
At the 6‐month follow‐up, participants will indicate
whether they are happy to be called for a short interview
about their experience of the trial; there is no additional
compensation for this telephone interview. Acceptability
will then bemeasured after the 6‐month follow‐up via tele-
phone interviews.
Participants will be asked whether they experienced
any unexpected consequences, adverse events or other
harms from participating in the study (in an open‐ended
Table 1 Schedule of enrolment and follow‐up assessments
Assessment Time‐point






Weekly alcohol consumption x x x x
AUDIT score and proportion of hazardous drinkers x x
Alcohol‐related problems or consequences and alcohol‐related injury x
Use of healthcare services x
Health‐related quality of life x
Psychological measures x x
Engagement x x x x
Acceptability x
Adverse events x x x
Debriefing x
a
Sociodemographic characteristics include: age, sex, ethnicity, education, occupation, income.
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question at the 1‐, 3‐ and 6‐month follow‐up) andwhether
they have used any other forms of support for alcohol re-
duction (at the 6‐month follow‐up).
Debriefing
On completion of the trial, after the final follow‐up at
6 months, the comparator group will also be informed
about the intervention, Drink Less.
MEASURES
Sociodemographic measures
Sociodemographic measures will be assessed at baseline:
age (in years, continuous), sex (% female), ethnicity (%
white), education (% post‐16 educational qualifications),
occupation (to derive social grade AB, C1, C2, D, E
dichotomised into: ABC1 [managerial, professional and in-
termediate occupations] vs. C2DE [skilled, semi‐skilled, un-
skilled manual and lowest‐grade worked or unemployed])
and annual household income (% >£26 000 [29]).
COVID‐19 measures
The recent COVID‐19 pandemic is affecting many aspects
of people’s lives in the UK. A lockdown is currently in place,
limiting many people’s ability to leave their homes, apart
from essential journeys. Early evidence suggests that
COVID‐19 may affect alcohol consumption, some lighter
drinkers are drinking less than usual and some heavier
drinkers are drinkingmore [30–33]. To assess for the effects
of the pandemic in the analysis, participants will respond to
a brief COVID‐19 survey at each time point. Users will be
asked ‘Do you currently feel like COVID‐19 is affecting your
alcohol consumption and howyou feel about drinkingalco-
hol?’ If participants respond ‘no’ theywill continuewith the
rest of the survey. Participants responding ‘yes’will be asked
to answer five follow‐up questions assessing the extent to
which the pandemic is affecting their concerns about their
alcohol consumption, their motivation to cut down and
their patterns of consumption. Change in concerns about
drinking will be measured by the question ‘Is COVID‐19
and its associated effects (e.g. financial, social or health)
currently affecting howworried you feel about your alcohol
consumption?’ followed by three response options: ‘more
worried’, ‘no change’ and ‘less worried’. Change inmotiva-
tion to reduce alcohol consumptionwill bemeasured by the
question ‘Is COVID‐19 and its associated effects currently
affecting your motivation to reduce your alcohol consump-
tion?’ with three response options: ‘more motivated’, ‘no
change’ and ‘less motivated’. Three questions measure
changes in drinking patterns. Change in the frequency of
drinking is measured by the question ‘Is COVID‐19 and its
associated effects affecting how frequently you consume al-
cohol?’ with three response options: ‘consume alcohol
more frequently’, ‘no change’ and ‘consume alcohol less
frequently’. Change in the volume of alcohol consumed is
measured by the question ‘Is COVID‐19 and its associated
effects currently affecting how many units of alcohol you
generally consume when you do drink?’ with three re-
sponse options: ‘generally drink more units’, ‘no change’
and ‘generally drink less units’. Finally, change in the fre-
quency of binge drinking is measured by the question ‘Is
COVID‐19 and its associated effects currently affecting
howoften you consume 6 ormore units of alcohol on a sin-
gle occasion?’ with three response options: ‘more likely to
consume 6 ormore units on a single occasion’, ‘no change’
and ‘less likely to consume 6 ormore units on a single occa-
sion’. The date of national responses to COVID‐19 (e.g. lock-
down) will also be monitored and recorded by the research
team.
Primary outcome measure
The primary outcomemeasure is change between baseline
and 6‐month follow‐up in self‐reportedweekly alcohol con-
sumption estimated over the last month, in UK standard
units. Change in weekly alcohol consumption will be de-
rived from the extended quantity‐frequency questions of
the AUDIT [34], adjusting for heavy episodic use (question
3 of the AUDIT) and therefore allocating an individual to a
category of consumption that is closest to their actual con-
sumption. The AUDIT‐C questions exhibit similar sensitiv-
ity and specificity to the full AUDIT [35] and have
demonstrated excellent reliability and responsiveness to
short‐term change [36]. The extended AUDIT‐C is a vari-
ant of the AUDIT‐C, which has a greater range of response
options (seven instead of five) on the quantity and fre-
quency items, therefore improving the granularity of the
information collected. This method of deriving alcohol con-
sumption has been used in other trials [37–40] and
has high levels of agreement in levels of self‐reported con-
sumption when compared with other retrospective daily
diary measures [41]. This measure minimises response
burden on participants because of its brevity, which is a
critical issue in digital trials that have minimal contact
with participants and can suffer from high levels of
attrition [42].
Secondary outcome measures
• Change between baseline and 1‐ and 3‐month follow‐
ups in self‐reported weekly alcohol consumption esti-
mated over the last 1 and 2 months, respectively;
• Heavy episodic alcohol use (measured using AUDIT
question 3) at 6‐month follow‐up
• Proportion of hazardous drinkers (AUDIT score ≥8);
• Alcohol‐related problems or consequences and
alcohol‐related injury (measured using the Alcohol
Short Index of Problems) [43] at 6‐month follow‐up;
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• Use of healthcare services (measured using the Service
Use Questionnaire) [44,45] at 6‐month follow‐up;
• Health‐related quality of life (measured using the EQ‐5D‐
5L) at 6‐month follow‐up.
The self‐report AUDIT questionnaire has 10 items that
measure alcohol consumption, harms and dependence.
The AUDIT is a reliable and standardised alcohol‐related
outcome measure that is commonly used in alcohol trials
[5,23]. It has a high test–retest reliability when completed
online [46], allows the derivation of a core outcome set for
consistency across trials andminimises research waste and
selective reporting [47]. The timeframe of the AUDIT will
be modified to refer to the past 6 months when asked at
the 6‐month follow‐up so this can be directly compared
with the baseline AUDIT, which will also refer to the
past 6 months. The extended AUDIT‐C when asked at the
1‐ and 3‐month follow‐up will refer to the past 1 month
and 2months, respectively, to capture participants’ alcohol
consumption since the last survey.
Process measures
The mixed‐methods process evaluation involves assessing
psychological measures, engagement and acceptability.
Psychological measures will be assessed as potential
mechanisms of action at baseline and 6‐month follow‐up
using four theoretical measures: urges to drink; motivation
to drink less; self‐regulatory and self‐monitoring capacity
(see Fig. 1 for the Logic Model). Strength of urges to drink
will be measured by the question ‘How strongly have you
felt the urge to drink alcohol in the past 24 hours?’ with
six options from ‘Not at all’ to ‘Extremely strong’. The
strength of urges to drink measure has been chosen be-
cause it can be done through a single item question and
has fair long‐term test–retest reliability [48]. The motiva-
tion to drink less will be measured with the single‐itemmo-
tivation to stop scale (MTSS). The MTSS and the urges to
drink measure are both used in the Alcohol Toolkit Study
allowing for national comparisons and have been success-
fully used in an observational study that estimates patterns
of alcohol consumption and reduction in a sample in En-
gland [49]. Self‐regulatory capacity will be measured by
‘How difficult do you find it to control your drinking?’ using
a 5‐point scale from ‘Not at all’ to ‘Extremely’.
Self‐monitoring capacity will be measured by ‘How often,
if at all, do you keep track of how many units of alcohol
you personally drink each week?’ ranging from ‘Never’ to
‘Always’.
Engagement with Drink Less will be assessed in terms of
app download, frequency, amount, duration and depth of
engagement [50]—all automatically recorded within the
app, among participants in the intervention group. This
will provide objective data on how participants interact
with the app. App download will be assessed by whether
the participant downloaded and opened Drink Less (a
binary yes/no measure). Frequency of engagement will
be assessed by number of sessions, where a new session is
defined as a new screen view after 30 minutes of inactiv-
ity [51]. Amount of engagement will be assessed by time
on app in minutes. Duration of engagement will be
assessed by number of days used. Depth of engagement will
be assessed by the percentage of available screens viewed.
Participants will also be asked about their use of the app
in the semi‐structured interviews to complement and en-
hance the patterns identified from the objective engage-
ment data. For example: ‘Can you tell me about your
experience of using the app?’ and ‘In what situations did
you use it and why?’ Adherence to either the intervention
or comparator will bemeasured at 1‐month follow‐upwith
the self‐report question ‘Did you look at or use the digital
tool we recommended?’ with options Yes/No. Participants
are informed that their answer itself does not matter and
that they are still eligible to take part, but that their answer
will help the researchers to draw more accurate
conclusions.
The acceptability of the intervention will be assessed in
a number of short semi‐structured interviews among a
sub‐sample of participants in both the intervention and
comparator group after the 6‐month follow‐up. The inter-
view will focus on perceptions of the intervention in terms
of the acceptability of the app—the extent to that partici-
pants consider the app to be appropriate, based on antici-
pated or experienced cognitive and emotional responses
to the intervention [52]. The interview topic guide will be
based on the Theoretical Framework of Acceptability [52].
Economic measures
Unit costs for the economic evaluation will be taken from
standard sources (e.g. Personal Social Services Research
Unit [PSSRU] and NHS tariffs).
Data management and monitoring
Baseline and follow‐up assessment data will be collected
online in Qualtrics and then held securely in Data Safe
Haven. All personal data will be pseudonymised. Engage-
ment data will be collected automatically from the app
and downloaded via python/pandas script into Data Safe
Haven from a secure https protocol and ‘Nodechef ’ (an on-
line platform for hosting mobile apps). The audio recording
of the semi‐structured interviews on acceptability will be
pseudonymised and transferred directly from the recording
device to Data Safe Haven. Any participant who opts out of
the study will have their data deleted.
An independent data monitoring committee will have
access to the unblinded comparative data and will monitor
these data. The committee will make recommendations on
whether there are any reasons to terminate the trial that
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the chair will report to the independent trial steering
committee.
Analysis
The datawill be analysed using R Studio [53]. The data an-
alyst will be blinded to participants’ group and the analysis
plan will be finalised and uploaded onto Open Science
Framework before the start of data analysis when the trial
will be analysed in accordance with the pre‐specified plan.
Descriptive statistics of participants’ sociodemographic
characteristics and AUDIT score will be reported for
whom the study recruited andwho then accessed the inter-
vention. The difference between the intervention and
comparator groups on baseline characteristics will be
assessed using one‐way ANOVAs for continuous variables
(age, AUDIT score) and 2‐sided χ2 tests (or Fisher’s exact
test for rare events) for categorical variables (sex, ethnicity,
education, occupation, income and COVID‐19 survey
measures).
ANOVAs are generally considered robust against small
deviations from the normality assumption with only a
small effect on the type I error rate [54]. However, if there
is evidence of significant deviation we will attempt to
resolve this with transformations (e.g. logarithmic or
square‐root transformations) or choose the nonparametric
Kruskal‐Wallis H test, which does not require the assump-
tion of normality.
Analysis of primary and secondary outcomes
The primary analysis will use a conservative intention‐to‐
treat approach to missing data with the assumption of no
change for participants who do not respond to follow‐up
(i.e. analysis of outcome data from all randomised partici-
pants). The effect of group allocation on the primary out-
come, change in weekly alcohol consumption, will be
examined with an adjusted regression model, adjusting
for baseline consumption [55–57].
A secondary analysis will be conducted to assess differ-
ences in change in weekly alcohol consumption using an
unadjusted regression model. Regression models have sev-
eral statistical assumptions that will be assessed (i.e. the er-
rors of the data are normally distributed and there is equal
variances between treatments). The analyses are robust to
slight deviations in parametric assumptions, but where
large deviations are found data transformations and appro-
priate non‐parametric tests will be considered.
Additional sensitivity analyses will be conducted for the
primary outcome at 6 months: (i) responders‐only (i.e.
those who completed the 6‐month follow‐up survey); (ii)
using multiple imputation for non‐responders on baseline
characteristics (with five imputed data sets [58] combined
using Rubin’s rules [59]) and assuming a normal distribu-
tion with a mean of 0 and SD reflecting the variation in
change among responders; (iii) per‐protocol approach
whereby only participants who downloaded Drink Less in
the intervention group and those who viewed the NHS al-
cohol advice webpage in the comparator group are in-
cluded in the analyses, and whereby participants whose
treatment was contaminated are excluded; (iv) an instru-
ment variable analysis accounting for non‐use in the inter-
vention group and contamination in the comparator by
operationalising the difference in app usage between the
two conditions; (v) last observation carried forward; and
(vi) assessing the effect of the condition by recruitment
source.
Secondary analyses will assess: (i) the secondary out-
comes at 6 months using ANOVA and χ2 analyses as ap-
propriate and (ii) the change over time in the primary
outcome using 1‐ and 3‐month follow‐up data.
Confidence intervals, effect sizes (partial η2 for ANOVA
analyses, odds ratios for χ2 and regression analyses) and
exact P values will be reported. Bayes factors will be calcu-
lated using a half normal distribution to specify the pre-
dicted effect (of a 2 UK unit reduction per week) with a
peak at 0 (no effect) and the SD equal to the expected effect
size with Robustness Regions reported to specify the range
of expected effect sizes that support the same conclusion
[60].
Finally, interactions will be assessed between group al-
location with age, sex, ethnicity, education, occupation, in-
come and COVID‐19 measures (survey and national
responses) for primary and secondary outcomes. Where
significant interactions are found the findings will be strat-
ified, drawing on the PROGRESS‐Plus framework to explic-
itly consider health equity between the intervention and
comparator group [61].
Process evaluation
The process evaluation will involve quantitative analysis of
the psychological and engagement measures and qualita-
tive analysis of interview transcripts relating to the accept-
ability of the intervention.
The extent of user engagement with Drink Less will be
evaluated through descriptive statistics of the engagement
measures. Detailed modelling of variations between partic-
ipants will be conducted to explore variation in engage-
ment and psychological measures by sociodemographic
characteristics, baseline AUDIT scores and COVID‐19mea-
sures (survey and national responses). A mediation analy-
sis will be conducted to determine if any effect of group
allocation on the primary outcome is mediated by changes
in the psychological measures. The psychological measures
will also be integrated into the modelling of effectiveness
outcomes for Drink Less to identify links between the
outcomes, participant engagement and psychological
measures.
420 Claire Garnett et al.
© 2020 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction Addiction, 116, 412–425
Anonymised interview transcripts on the intervention’s
acceptability will be analysed using a combined framework
and thematic analysis approach. This involves initially cod-
ing participant responses according to the Theoretical
Framework of Acceptability construct they are judged to
represent best, then grouping similar responses within
each construct inductively to generate content themes
representing how that construct contributes to reported
acceptability. Twenty‐six participants will be interviewed
initially (13 from each group) [24], then data will be
analysed and data collection will continue in an iterative
process (adding 10 participants at a time) until thematic
‘meaning’ saturation is reached. Meaning saturation is de-
fined as the point at which the issues are fully understood
and no further dimensions, nuances or insights are found
[62].
Health economic evaluation
The economic evaluation will take a two‐stage approach to
analyse the cost‐utility of Drink Less from the NHS perspec-
tive. The first stage will be an analysis of the
cost‐effectiveness of the app in the trial population over
the duration of the trial itself (including follow‐up). Costs
will include the cost of the interventions in both arms
and the cost of NHS resource use (i.e. cost of changes in ser-
vice use and treatments). The cost‐effectiveness analysis
will take into account the total development cost of Drink
Less but keep it separate from the incremental evaluation
because there are no anticipated additional costs per user
using the app. Effects will be measured in terms of (i) reduc-
tion in alcohol consumption and (ii) health‐related quality
of life, measured in quality‐adjusted life years (QALYs). The
cost‐utility will be measured in terms of Incremental Cost‐
Effectiveness Ratio, the ratio between the difference in costs
and difference in effects between the intervention and com-
parator groups.
As there can be a delay of several years between reduc-
tions in alcohol consumption and improvements in health
[63], the full impacts of interventions designed to reduce
alcohol consumption on health and healthcare costs may
not be seen until well beyond the time horizon of an RCT.
The second stage of the economic evaluation will address
this limitation by using the established and widely‐used
Sheffield Alcohol Policy Model [64,65] to assess the
longer‐term cost‐effectiveness of the intervention, if rolled
out on a national level through active promotion to the
public, over a 20‐year time horizon.
Both short‐ and long‐term evaluations will assess
the impact on health inequalities using a Distribution
Cost‐Effectiveness Analysis framework [66,67]. Costs and
QALY outcomes will be estimated separately by socioeco-
nomic group, defined by social grade (AB, C1, C2, D or
E). These group‐specific results will be combined with
estimates of health pre‐intervention and the opportunity
cost of additional healthcare spending to place the inter-
vention on the ‘health equity impact plane’. Published esti-
mates of inequality aversion, quantifying the extent to
which society is willing to trade off changes in
cost‐effectiveness for changes in health inequalities, will
be used to identify the optimal strategy after accounting
for the inequality impacts of each approach.
Ethical approval
Ethical approval has been obtained from UCL Research
Ethics Committee (16799/001).
Dissemination policy
Results will be disseminated by open‐access peer‐reviewed
journal articles, presentations at scientific conferences,
press releases, a stakeholder workshop and blog posts.
NIHR authorship guidelines will be followed. Study mate-
rials, anonymised data and code will be made available
on Open Science Framework (on the project page:
https://osf.io/q8mua), and the source code for the app will
be released under the GNU General Public License (v3) on
GitHub.
DISCUSSION
This study will provide evidence on the effectiveness and
cost‐effectiveness of the Drink Less app—a theory‐ and ev-
idence‐informed intervention—for the reduction of haz-
ardous and harmful alcohol consumption. The embedded
mixed‐methods process evaluation will evaluate the extent
of user engagement with Drink Less and whether user en-
gagementmoderates or changes in psychologicalmeasures
mediate the effectiveness of the intervention and partici-
pants’ views on the acceptability of the intervention. Fur-
thermore, the use of behavioural science in the
development and refinement of the Drink Less app and
the trial methodology will improve the understanding of
what works for whom and why. Drink Less collects detailed
user engagement and behavioural data of potential value
in advancing its underpinning theory [68], which can in-
form future behaviour change interventions. The princi-
ples of Open Science will continue to be followed, which
is important for efficient scientific progress.
Drink Less is in a good position for future implementa-
tion in healthcare settings because it is already aligned
with the criteria from the NHS Digital Assessment Ques-
tionnaire and with the NICE Evidence for Effectiveness
Framework and Code of Conduct for Digital Health [69–
71]. The app will be submitted to the NHS Apps Library if
found to be effective, which may result in healthcare prac-
titioners recommending or prescribing the app to patients
Evaluating the Drink Less app: RCT protocol 421
© 2020 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction Addiction, 116, 412–425
[72]. Drink Less is a standalone app and therefore, in a
strong position to be actively promoted on a national level,
through media contacts and relevant organisations, to en-
courage use of the app amongst wider society. A sustain-
ability model will be developed as part of this research
project to maximise the impact of the app by enabling
long‐term planning for its implementation, adoption and
future development and will inform the long‐term eco-
nomic analysis in terms of potential reach and costs. A cur-
rent limitation is that Drink Less is only available on iOS
devices though this RCT will provide a proof of concept
and strong rationale, if effective, for developing a native
Android version, which would maximise the potential im-
pact of Drink Less on public health. A potential limitation
of the trial is the choice of the NHS website as the compar-
ator instead of an app‐based intervention that would allow
us to directly compare the recommendation to download
one of two apps. However, using the NHS website as the
comparator condition is of direct policy relevance and
strengthens the public health impact of the study.
There are two main anticipated challenges with this
trial: recruitment and retention rates that we have
attempted to minimise as follows. A multi‐pronged recruit-
ment strategy is planned, including placing an advert on a
NHS webpage, which provides the ability to access a large
number of drinkers. A higher rate of recruitment than is
currently required (265 participants per month) was
achieved in the factorial trial of Drink Less (355 permonth)
[13] with web‐based recruitment and screening. However,
a contingency plan is in place that involves advertisements
placed on Google and Facebook (following the methods
used in a similar trial [73]) and use of a recruitment com-
pany. We will also calculate Bayes factors, which in the sit-
uation of under recruitment will allow us to distinguish
between two interpretations of a non‐significant result: (i)
support for the null hypothesis of ‘no effect’ and (ii) data
are insensitive to detect an effect [74,75]. To maximise
the overall retention rate, financial incentives will be of-
fered as a reasonable acknowledgement of participants’
time, and a range of methods will be used for follow‐up
contact sequentially, which has been shown to improve re-
sponse rates [76]. The trial cost per participant and
methods of follow‐up contact are comparable with similar
studies that achieved high retention rates [73,77]. The in-
tention‐to‐treat approach to analysis is conservative,
meaning that if a follow‐up rate similar to that in other tri-
als is achieved, then if anything the effect size will be an
underestimate.
We acknowledge that the research team is evaluating
an app that it has developed and that there may be a per-
ceived bias. The team have no financial stake in the app
and the code is available in Github by the GNU General
Public License (v3). The trial has been designed to meet
the Cochrane Risk of Bias criterion of ‘low risk’ andwe have
followed best practice guidelines to ensure a robust evalua-
tion is conducted, including blinding and oversight by inde-
pendent trial steering and data monitoring committees.
The data will be analysed in accordance with a
pre‐specified analysis plan approved by the committees
and uploaded onto Open Science Framework before the
start of data analysis.
CONCLUSIONS
This study will be the first RCT of an alcohol reduction app
for the general population in the United Kingdom, thereby
starting to build a strong evidence base on the effectiveness
and cost‐effectiveness of health‐related apps. The RCT will
be able to directly inform the pragmatic question of inter-
est: whether it is worth investing resources into promoting
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